Prevalence and risk factors of urinary tract infection in kidney recipients: a meta-analysis study

BMC Nephrology - Tập 24 - Trang 1-13 - 2023
Masoumeh Hosseinpour1, Aiyoub Pezeshgi2, Morteza Zaboli Mahdiabadi3, Foroogh Sabzghabaei4, Hamed Hajishah5, Soheila Mahdavynia4
1Faculty of Medical Sciences, Tabriz Branch, Islamic Azad University, Tabriz, Iran
2Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
3Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
4Firoozabadi Clinical Research Development Unit (FACRDU), Iran University of Medical Sciences, Tehran, Iran
5Student Research Committee, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran

Tóm tắt

A kidney recipient's urinary tract infection (UTI) can result in infectious problems and be a risk factor for less successful transplant outcomes. UTI risk factors are still controversial. The present study aimed to investigate the prevalence of UTI and its association with risk factors in kidney recipients. Twenty-six papers published between 2005 and 2022 were retrieved using keywords and searching Medlib, ScienceDirect, PubMed, and other databases. If possible, the pooled prevalence of UTI in kidney recipients and odds ratio (OR) with a 95% confidence interval for each risk factor were calculated. The data were analyzed using the random effects model in R and Stata 14. The total sample size was 72,600, with an average age of 48.7 years. The pooled prevalence of UTI was 35% (95% CI, 30–40%). The estimated risk factors for UTI were female (OR = 3.13; 95%CI: 2.35—4.17), older age (OR = 1.03; 95%CI: 1—1.05), history of UTI (OR = 1.31; 95%CI) CI: 1.05—1.63), receiving a kidney from a deceased donor (OR = 1.59; 95%CI: 1.23—2.35), long-term use of an indwelling catheter (OR = 3.03; 95%CI: 1.59—6.59), a ureteral stent (OR = 1.54; 95%CI: 1.16—2.06), diabetes (OR = 1.17; 95%CI: 0.97—1.41), hypertension (OR = 1.6; 95%CI: 1.26—2.28), acute rejection process (OR = 2.22; 95%CI: 1.45—3.4), and abnormal urinary tract anatomy (OR = 2.87; 95%CI 1.44—5.74). This meta-analysis revealed that UTIs are a significant problem in kidney recipients. Factors such as female sex, old age, history of UTIs, deceased donor, long-term use of an indwelling catheter, diabetes, acute rejection process, use of ureteral stent, abnormal urinary tract anatomy, and hypertension were related to an increased risk of UTIs in kidney recipients.

Tài liệu tham khảo

Eggers pw. Effect of renal transplantation on the medical end- stage renal disease program. NEJ Med. 1988; 318223. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med. 1998;338:1741–51. Bretan PN, Malone MJ. Renal transplantation. In: Tanagho EA, McAninch JW, editors. Smith’s General Urology. 15th ed. New York: Lange Medical/McGraw-Hill; 2000. p. 614–27. Maraha B, Bonten H, van Hooff H, Fiolet H, Buiting AG, Stobberingh EE. Infectious complications and antibiotic use in renal transplant recipients during a 1-year follow-up. ClinMicrobiol Infect. 2001;7:619–25. Alangaden GJ, Thyagarajan R, Gruber SA, Morawski K, Garnick J, El-Amm JM. Infectious complications after kidney transplantation: current epidemiology and associated risk factors. Clin Transplant. 2006;20:401–9. Chuang P, Parikh CR, Langone A. Urinary tract infections after renal transplantation: a retrospective review at two US transplant centers. Clin Transplant. 2005;19:230–5. Rubin RH. Infectious disease complications of renal transplantation. Kidney Int. 1993;44:221–36. Jamil B, Nicholls K, Becker GJ, Walker RG. Impact of acute rejection therapy on infections and malignancies in renal transplant recipients. Transplantation. 1999;68:1597–603. Charfeddine K, Zahden S, Kharrat M. Infectious complications in kidney transplant recipients. Transplant Proc. 2005;37:2823. Joseph R. Masci, Gary P. Wormser. Mandell, Douglas, Bennett's. principles and practice of infectious Diseases. Sixth ed. Philudelphia, Pennsylvania: Elsevir; 2005: 3503. Wojciechowski D, Chandran S. Effect of ciprofloxacin combined with sulfamethoxazole-trimethoprim prophylaxis on the incidence of urinary tract infections after kidney transplantation. Transplantation. 2013;96:400–5. Karuthu S, Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol. 2012;7:2058–70. Lee JR, Bang H, Dadhania D. Independent risk factors for urinary tract infection and for subsequent bacteremia or acute cellular rejection: A single-center report of 1166 kidney allograft recipients. Transplantation. 2013;96:732–8. Shin DH, Kim EJ, Lee S, Kim SJ, Oh J. Early-onset graft pyelonephritis is predictive of long-term outcome of renal allografts. Tohoku J Exper Med. 2015;236:175–83. Abbott KC, Oliver JD, Hypolite I, Lepler LL, Kirk AD, Ko CW. Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol. 2001;21:120–7. Brayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DE. Analysis of infectious complications occurring after solid-organ transplantation. Arch Surg. 1992;127:38–47. Ramsey D E, Finch W T. Birteh A G. Urinary tract infection in kidney transplant recipients. Arch Surg. 1979;114: 1022–5. Rao KV, Andersen RC. Long-term results and complications in renal transplant recipients. Observations in the second decade Transplantation. 1988;45:45. Grekas D, Thanos V, Dioudis C. Treatment of urinary tract infections with ciprofloxacin after renal transplantation. Int J Clin Pharmacol Ther Toxicol. 1993;31:309. Gargah T, Labessi A, Ounissi M, Derouiche A, Chokri Z, Trabelsi M. Early infections in children following renal transplantation. Tunis Med. 2011;89:26–30. Viale P, Scudeller L. Infectious complications after renal transplantation. G Ital Nefrol. 2004;26:48–52. Kawecki D, Kwiatkowski A, Michalak G, Sawicka- Grzelak A, Mlynarczyk A, Sokol-Leszczynska B. Etiologic agents of bacteremia in the early period after simultaneous pancreas-kidney transplantation. Transplant Proc. 2009;41:3151–3. Takai K, Tollemar J, Wilczek HE, Groth CG. Urinary tract infections following renal transplantation. Clin Transplant. 1998;12:19–23. Papasotiriou M, Savvidaki E, Kalliakmani P, Papachristou E, Marangos M, Fokaefs E. Predisposing factors to the development of urinary tract infections in renal transplant recipients and the impact on the long-term graft function. Ren Fail. 2011;33:405–10. Miranda C, Carazo C, Bañón R, Mendoza J, Montes A, de la Rosa M. Mycoplasma hominis infection in three renal transplant patients. Diagn Microbiol Infect Dis. 1990;13:329–31. Abbott KC, Swanson SJ, Richter ER. Late urinary tract infection after renal transplantation in the United States. Am J Kidney Dis. 2004;44:353. Di Cocco P, Orlando G, Mazzotta C, et al. Incidence of urinary tract infections caused by germs resistant to antibiotics commonly used after renal transplantation. Transplant Proc. 2008;40:1881. Lyerova L, Viklicky O, Nemcova D. The incidence of infectious diseases after renal transplantation: a single-centre experience. Int J Antimicrob Agents. 2008;31:S58. Abbott KC, Oliver JD, Hypolite I. Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol. 2001;21:120. Memikoğlu KO, Keven K, Sengul S, Soypacaci Z, Erturk S, Erbay B. Urinary tract infections following renal transplantation: a single-center experience. Transplant Proc. 2007;39:3131–4. Wu X, Dong Y, Liu Y, Li Y. The prevalence and predictive factors of urinary tract infection in patients undergoing renal transplantation: A meta-analysis. Am J Infect Control. 2016;44:1261–8. Lopez-Medrano F, Garcia-Bravo M, Morales JM. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: an underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study. Clin Infect Dis. 2008;46:825–30. Vidal E, Torre-Cisneros J, Blanes M. Bacterial urinary tract infection after solid organ transplantation in the RESITRA cohort. Transpl Infect Dis. 2012;14:595–603. Pelle G, Vimont S, Levy PP, Hertig A, Ouali N, Chassin C. Acute yelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant. 2007;7:899–907. Alevizakos M, Nasioudis D, Mylonakis E, Diseases DI. Urinary tract infections due to ESBL-producing Enterobacteriaceae in renal transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2017;19:12759. Hossein Zadegan H, Hassani A, Azadpour M, Suleiman NS. Identification of beta-lactamase-producing gram-negative bacilli of a wide range of bacteria isolated from clinical cases. Laboratory Science Journal. 2007;2:21–5. Vasudevan R. Urinary tract infection: an overview of the infection and the associated risk factors. Microbiol Exp. 2014;1:42–54. Osman Y, li-El-Dein B, Shokeir AA, Kamal M, El-Din AB. Routine insertion of ureteral stent in live-donor renal transplantation: is it worthwhile? Urology. 2005; 65: 867–71. Dantas SR, Kuboyama RH, Mazzali M, Moretti ML. Nosocomial infections in renal transplant patients: risk factors and treatment implications associated with urinary tract and surgical site infections. J Hosp Infect. 2006;63:117–23. Pourmand G, Salem S, Mehrsai A, Taherimahmoudi M, Ebrahimi R, Pourmand MR. Infectious complications after kidney transplantation: a single-center experience. Transpl Infect Dis. 2007;9:302–9. Sqalli TH, Laboudi A, Arrayhani M. Urinary tract infections in renal allograft recipients from living related donors. Saudi J Kidney Dis Transpl. 2008;19:551–3. Bonkat G, Rieken M, Siegel FP, Frei R, Steiger J, Groschl I. Microbial ureteral stent colonization in renal transplant recipients: frequency and influence on the short-time functional outcome. Transpl Infect Dis. 2012;14:57–63. Sorto R, Irizar SS, Delgadillo G, Alberu J, Correa-Rotter R, Morales-Buenrostro LE. Risk factors for urinary tract infections during the first year after kidney transplantation. Transplant Proc. 2010;42:280–1. Safdar N, SlatteryWR, Knasinski V. Predictors and outcomes of candiduria in renal transplant recipients. Clin Infect Dis. 2005; 40: 1413–21. Bodro M, Sanclemente G, Lipperheide I, Allali M. Impact of Urinary tract infections in short-term kidney graft outcome. Clin Microbiol Infect. 2015;21:1104.e8. Tavakoli A, Surange RS, Pearson RC, Parrott NR, Augustine T, Riad HN. Impact of stents on urological complications and health care expenditure in renal transplant recipients: results of a prospective, randomized clinical trial. J Urol. 2007;177:2260–4. Mathe Z, Treckmann JW, Heuer M, Zeiger A, Sauerland S, Witzke O. Stented ureterovesical anastomosis in renal transplantation: does it influence the rate of urinary tract infections? Eur J Med Res. 2010;15:297. Dominguez J, Clase CM, Mahalati K, MacDonald AS, McAlister VC, Belitsky P, et al. Is routine ureteric stenting needed in kidney transplantation? A randomized trial Transplantation. 2000;70:597–601. Giakoustidis G, Diplaris K, Antoniadis N, Papagianis A, Ouzounidis N, Fouzas I, et al. Impact of double-J ureteric stent in kidney transplantation: single-centre experience. Transplant Proc. 2008;40:3173–5. Tolkoff-Rubin NE, Rubin RH. Urinary tract infection in the immunocompromised host: lessons from kidney transplantation and the AIDS epidemic. Infect Dis Clin North Am. 1997;11:707–17. Schmaldienst S, Horl WH. Bacterial infections after renal transplantation. Nephron. 1997;75:140–53. Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Acute graft pyelonephritis following renal transplantation. Transpl Infect Dis. 2006;8:140–7. Rabkin DG, Stifelman MD, Birkhoff J, Richardson KA, Cohen D, Nowygrod R. Early catheter removal decreases incidence of urinary tract infections in renal transplant recipient. Transplant Proc. 1998;30:4314–6. Gołe˛biewska J, De˛bska-S´ lizien´ A, Komarnicka J, Samet A, Rutkowski B. Urinary tract infections in renal transplant recipients. Transplant Proc. 2011; 43:2985- 90. Veroux M, Giuffrida G, Corona D, Gagliano M, Scriffignano V, Vizcarra D. Infective complications in renal allograft recipients: epidemiology and outcome. Transplant Proc. 2008;40:1873–6. Glazier DB, Jacobs MG, Lyman NW, Whang MI, Manor E, Mulgaonkar SP. Urinary tract infection associated with ureteral stents in renal transplantation. Can J Urol. 1998;5:462–6. Goya N, Tanabe K, Iguchi Y, et al. Prevalence of urinary tract infection duringoutpatient follow-up after renal transplantation. Infection. 1997;25:101–5. Rivera-Sanchez R, Delgado-Ochoa D, Flores-Paz RR, et al. Prospective study of urinary tract infection surveillance after kidney transplantation. BMC Infect Dis. 2010;10:245. Midtvedt K, Hartmann A, Midtvedt T, Brekke IB. Routine perioperative antibiotic prophylaxis in renal transplantation. Nephrol Dial. 1998;13:1637–41. Munoz P. Management of urinary tract infection and Lymphocele in renal transplant recipients. Clin infect Dis. 2001;33:53–7. Espinar MJ, Miranda IM, osta-de-Oliveira S, Rocha R. Urinary Tract Infections in Kidney Transplant Patients Due to Escherichia coli and Klebsiella pneumoniae-Producing Extended-Spectrum β-Lactamases: Risk Factors and Molecular Epidemiology. PLOS ONE. 2015; 10: e0134737. Britt N, Hagopian JC, Brennan DB. Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation. Nephrol Dial Transplant. 2017;32:1758–66. Ullah H, Khan N, Malik A, Raman AU. Frequency of urinary tract infections in renal transplant recipients with common bacteria and its sensitivity. Pak-Euro J Med Life Sci. 2022;5:223–8. Kasiske BL, Zeier MG, Chapman GR. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77:299–311. Hewitt IK, Pennesi M, Morello W. Antibiotic Prophylaxis for Urinary Tract Infection-Related Renal Scarring: A Systematic Review. Pediatrics. 2017;139:e20163145. Gaston RS, Basadonna G, Cosio FG, Davis CL, Kasiske BL, Larsen J. Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis. 2004;44:529–42. Ariza-Heredia EJ, Beam EN, Lesnick TG, Cosio FG. Impact of urinary tract infection on allograft function after kidney transplantation. Clin Transplant. 2014;28:683–90. Saemann M, Horl WH. Urinary tract infection in renal transplant recipients. Eur J Clin Invest. 2008;38:58–65. Gołe˛biewska J, De˛bska-S´ lizien´ A, Komarnicka J, Samet A, Rutkowski B. Urinary tract infections in renal transplant recipients. Transplant Proc. 2011; 43:2985- 90. Farr A, Gyori G, Muhlbacher F, Husslein P, Bohmig GA, Margreiter M. Gender has no influence on VUR rates after renal transplantation. Transpl Int. 2014;27:1152–8. Giullian JA, Cavanaugh K, Schaefer H. Lower risk of urinary tract infection with low-dose trimethoprim/sulfamethoxazole compared to dapsone prophylaxis in older renal transplant patients on a rapid steroid-withdrawal immunosuppression regimen. Clin Transplant. 2010;24:636–42. Pelle G, Vimont S, Levy PP, Hertig A, Ouali N, Chassin C, et al. Acute yelonephritis represents a risk factor impairing long-term kidney graft function. Am J Transplant. 2007;7:899–907. Memikoğlu KO, Keven K, Sengul S, Soypacaci Z, Erturk S, Erbay B. Urinary tract infections following renal transplantation: a single-center experience. Transplant Proc. 2007;39:3131–4. Lopez-Medrano F, Garcia-Bravo M, Morales JM, et al. Urinary tract infection due to Corynebacterium urealyticum in kidney transplant recipients: an underdiagnosed etiology for obstructive uropathy and graft dysfunction-results of a prospective cohort study. Clin Infect Dis. 2008;46:825–30. Bodro M, Sanclemente G, Lipperheide I. Impact of Antibiotic Resistance on the Development of Recurrent and Relapsing Symptomatic Urinary Tract Infection in Kidney Recipients. Am J Transplant. 2015;15:1021–7. Królicki T, Bardowska K, Kudla T, Królicka A. Acute kidney injury secondary to urinary tract infection in kidney transplant recipients. Sci Rep. 2022;12:10858. Naik A, Dharnidharka VR. Schnitzler MA, Brennan DB. Clinical and economic consequences of first-year urinary tract infections, sepsis, and pneumonia in contemporary kidney transplantation practice. Transplant International. 2016; 29: 241–52. Liu S, Luo G, Sun B, Lu J, Zu Q. Early Removal of Double-J Stents Decreases Urinary Tract Infections in Living Donor Renal Transplantation: A Prospective, Randomized Clinical Trial. Transplantation Proceedings. 2017; 49: 297e302. Mansury D, Khaledi A, Ghazvini K, Ghorban SM. Study of Bacterial Infections Among Patients Receiving Kidney Transplant in Mashhad. Iran Experimental and Clinical Transplantation. 2018;3:282–6. Simsek C, Karatas M, Tatar E, Tercan IC, TasliAlkan F, Uslu A. Acute Allograft Pyelonephritis: Vague Symptoms, Indeterminate Laboratory Results, and the Necessity of Indication Biopsy. Exp Clin Transplant. 2022;20(Suppl 1):117–24. https://doi.org/10.6002/ect.MESOT2021.P51. (PMID: 35384820). Pacaud M, Colas L, Kerleau C, Le Borgne F, Giral M, Brouard S, Dantal J. Impact of Late and Recurrent Acute Graft Pyelonephritis on Long-Term Kidney Graft Outcomes. Front Immunol. 2022 Mar 2;13:824425. doi: https://doi.org/10.3389/fimmu.2022.824425. PMID: 35418982; PMCID: PMC8998071.